Xenoport Inc. Files SEC Form 4: Shareholder and Officer Transactions

Strategic Insights -

Xenoport Inc., a pharmaceutical company, filed a form 4 with the Securities and Exchange Commission (SEC) on July 15, 2015, disclosing transactions involving shareholders and officers. The SEC filing is a formal document or financial statement submitted by publicly-traded companies to provide transparency on ownership and financial activities.

Key Takeaways:

  • The SEC filing is required for companies listed on Section 12 of the '34 Act, where individuals holding more than 10% of a class of equity securities must report their transactions.
  • The filing provides information on the reporting person's relationship to the company and purchases and sales of equity securities.
  • Xenoport Inc.'s SIC code is 2834, indicating it operates in the Pharmaceutical Preparations industry.
  • The company's contact information is listed as 3410 CENTRAL EXPRESSWAY, SANTA CLARA, CA 95051, with a phone number of 408-616-7200.
  • Form 4 is used to report changes in ownership and is part of the periodic reporting requirements for publicly-traded companies.

Statistics:

  • SIC code for Xenoport Inc.: 2834
  • Permitted business activity: Pharmaceutical Preparations
  • Company contact information: 3410 CENTRAL EXPRESSWAY, SANTA CLARA, CA 95051
  • Phone number: 408-616-7200
  • SEC file number: 0001209191-15-060991

Sources:

  • NewsRx LLC, original reporting
  • U.S. Securities and Exchange Commission (SEC), disclosure requirements
  • Xenoport Inc., Form 4 filing (0001209191-15-060991)